Lupin Pharmaceuticals Inc et al. vs. Pozen Inc. et al.
Explore the PTAB proceeding IPR2015-01774 filed by Lupin Pharmaceuticals Inc et al. on 2015-08-19. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2015-01774
Filing Date
2015-08-19
Accorded Filing Date
2015-08-19
Institution Decision Date
2016-03-01
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
2016-03-01
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Lupin Pharmaceuticals Inc et al.
Represented By
Patel, Saileshet alPatent Owner / Respondent
Pozen Inc. et al.
Represented By
Rodriguez, Ricardoet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
2 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (2)
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 13 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 8,852,636 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,865,190 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,858,996 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,161,920 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,198,888 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,345,695 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,364,439 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,707,181 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 29,458,801 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 6,926,907 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,206,741 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2010017298 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,557,285 B2 | US Continuation / Sibling | View Official Patent → |
Lupin Pharmaceuticals Inc. et al. v. Pozen Inc. et al.
Lupin Pharmaceuticals Inc. et al. v. Pozen Inc. et al.
Coalition for Affordable Drugs VII LLC et al. v. Pozen Inc. et al.
Coalition for Affordable Drugs VII LLC et al. v. Pozen Inc. et al.
Coalition for Affordable Drugs VII LLC et al. v. POZEN Inc. et al.
Dr. Reddy's Lab., Inc. et al. v. Pozen Inc. et al.
HORIZON PHARMA, INC. v. ACTAVIS LABORATORIES FL., INC.